KALA BIO sells $4.2M Series AAA Preferred, board control shifts to AK Holdings

KALA BIO, Inc.

Company issued 2.1M shares of Series AAA Preferred at $2/sh, raising $4.2M; each share convertible into 420 common shares (882M total potential shares).
AK Holdings appointed five directors: Avi Minkowitz, Hillel Posen, Chaim Berger, Yonatan Colman, Brendan Purdy, replacing prior board.
Stockholders approved increase in authorized common shares to 1.5B and authorized reverse stock split (1:2 to 1:100).
Six prior directors resigned (Marjan Farid, Andrew Koven, Mark Iwicki, Todd Bazemore, C. Daniel Meyers, Howard Rosen).

item 1.01 item 3.02 item 5.01 item 5.02 item 5.03 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001829126-26-000837
form_type: 8-K
ticker: KALA
cik: 0001479419
company_name: KALA BIO, Inc.
filed_at: 2026-02-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.169678+00:00
generated_at: 2026-05-16T05:34:59.918991+00:00
sec_items: ["1.01", "3.02", "5.01", "5.02", "5.03", "5.07", "9.01"]
event_type: m_and_a
sentiment: negative
materiality_score: 0.9
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001829126-26-000837
json_url: https://secwatch.observer/filing/0001829126-26-000837.json
markdown_url: https://secwatch.observer/filing/0001829126-26-000837.md
text_url: https://secwatch.observer/filing/0001829126-26-000837.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/0001829126-26-000837-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/kalabio_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001829126-26-000837

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.